Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

111 results about "Garcinia mangostana" patented technology

Mangosteen (Garcinia mangostana), also known as the purple mangosteen, is a tropical evergreen tree with edible fruit native to Island Southeast Asia. Its exact origins are unknown due to its widespread cultivation since ancient times, but it is believed to have been somewhere between the Sunda Islands and the Moluccas. It grows mainly in Southeast Asia, southwest India and other tropical areas such as Colombia, Puerto Rico and Florida, where the tree has been introduced. The tree grows from 6 to 25 m (19.7 to 82.0 ft) tall. The fruit of the mangosteen is sweet and tangy, juicy, somewhat fibrous, with fluid-filled vesicles (like the flesh of citrus fruits), with an inedible, deep reddish-purple colored rind (exocarp) when ripe. In each fruit, the fragrant edible flesh that surrounds each seed is botanically endocarp, i.e., the inner layer of the ovary. Seeds are almond-shaped and -sized.

Neutraceutical composition containing mangosteen pericarp extract

A neutraceutical beverage comprising pericarp extract from the Garcinia mangostana L. (mangosteen) plant, and juice from mangosteen fruit pulp, preferably combined with juice from at least one of four other ingredients selected from red grapes, lycium, sea buckthorn, and apple, preferably obtained from powdered extract of mangosteen pericarp and a mixture of fruit concentrate and / or powdered fruit and / or fruit extract In a preferred embodiment the neutraceutical beverage comprises mangosteen pericarp extract and juice from each of mangosteen fruit pulp, red grapes, lycium, sea buckthorn, and apple. The mangosteen pericarp extract can be obtained by a process in which mangosteen pericarp is extracted with ethanol, for example, a 50% ethanol, 50% water solution, and the extract is dried under vacuum. The beverage optionally can include one or more additional fruit juices or concentrates, or fruit or plant extracts, such as concord grape concentrate, blueberry concentrate, red raspberry concentrate, powdered green tea extract, powdered grape seed extract, and powdered grape skin extract.
Owner:NATURE'S SUNSHINE PRODUCTS

Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant

InactiveUS20060292255A1Strong antiseptic and antibacterial and antiviral effectEasy to produceAntibacterial agentsOrganic active ingredientsMedicineXanthone
The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.
Owner:RENAISSSANCE HERBS

Anti-skin damage compositions with complimentary dual mode of action

Disclosed are skin care compositions exerting a novel complementary dual mode of action in protecting the skin from day-to-day insults. The skin care compositions of the present invention comprise the extract from the liquid endosperm of Cocos nucifera as the principle ingredient along with one or more actives including the fruit rind extracts of Garcinia cambogia, Garcinia indica and Garcinia mangostana, seed coat extract of Tamarindus indicus, Chlorogenic acid extract from the beans of Coffea arabica, seed extracts of Nelumbo species, the leaf extracts of Murraya koenigii and the triterpene pentapeptides of oleanolic acid and ursolic acid. While the extract of Cocos nucifera has been included as a nutritional supplement (a natural cell culture medium) to ensure the maintenance of the viability and constant renewal of the cells of the skin, the other actives have been carefully chosen based on one or more of their effective skin care properties. The compositions of the present invention offer a safe prophylactic / therapeutic management solution to the wide range of pathological states associated with skin insults and the associated psycho-social issues.
Owner:SAMI LABS LTD

Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant

InactiveUS20060105069A1Avoiding unwanted potentially-cytotoxic effectReduce concentrationAntibacterial agentsOrganic active ingredientsMedicineXanthone
The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.
Owner:RENAISSANCE HERBS INC

Composition and method of treatment for irritated skin

InactiveUS20070098671A1Cosmetic preparationsBiocideIrritants skinGarcinia mangostana
A composition for application to irritated skin including honey, aloe, and a derivative of the mangosteen plant. The composition may also include a thickening agent. Also disclosed is a method of treating skin including the step of applying the composition to the skin.
Owner:MARTIN GREGORY D

Garcinia mangostana L. enhanced animal food product

The present invention advances prior art animal food products by providing an animal food product formulated with Garicinia mangostana L., or Mangosteen fruit, from the Mangosteen plant. The addition of Mangosteen to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.
Owner:TAHITIAN NONI INT INC

Acne removing skin care product and preparation method thereof

ActiveUS20170354834A1Promote salivationStop diarrheaAntibacterial agentsCosmetic preparationsMedicineGarcinia mangostana
Disclosed are an acne removal composition, a skin care product and a preparation method thereof, wherein the acne removal composition is made from Garcinia mangostana L pericarp, thyme and Fructus aurantii.
Owner:INFINITUS (CHINA) CO LTD

Hair growth formula

A hair treatment composition for topical application to the skin and / or hair, comprising partially hydrolyzed fucoidan and a pharmaceutical carrier. The composition may contain further additives. The carrier may be hydrophyllic or anhydrous. The composition may also include natural components such as honey and / or mangosteen. The composition may also include flavonoids, analgesics, radiation protecting agents, and / or anti-oxidants.
Owner:SAKURA PROPERTIES LLC

Anti-adipocyte fatty acid-binding protein (AP2), Anti-flap and Anti-cyslt1 receptor herbal compositions

Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of Boswellia serrata. More particularly, these herbal compositions comprise an effective amount of an enriched Boswellia extract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-β-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of Aegle marmelos, an extract of Zingiber officinale, an extract of Garcinia mangostana, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.
Owner:LAILA IMPEX

Andrographis paniculata gel as an adjunct in the treatment of periodontitis

A composition in the form of a biodegradable gel, chip or ointment is provided, for adjunct treatment of periodontitis, comprising: (i) an antimicrobial extract having antimicrobial or antibacterial activity against periodontal pathogens, preferably from one or more of the plants Andrographis paniculata, mangosteen (Garcinia mangostana) and turmeric (Curcuma longa); and (ii) a gel base containing a mixture of glyceryl monooleate and triglyceride. The composition is biodegradable, and forms a liquid crystal structure on contacting gingival fluid, which liquid crystal structure releases active ingredients gradually, to provide a sustained release dosage form.
Owner:MAHIDOL UNIV

Method for extracting alpha-mangostin from garcinia mangostana peel

The invention discloses a method for extracting alpha-mangostin from garcinia mangostana peel. The method includes the following steps that 1) the garcinia mangostana peel is crushed, reflux extraction is conducted once or twice with water of 8-10 times of weight, then reflux extraction is conducted for one to three times with a 90%-95% ethanol solution of 8-10 times of weight, an extracting solution of the ethanol solution is combined, the extracting solution is concentrated to be twice or three times of the weight of the garcinia mangostana peel, centrifuging is carried out, and after centrifugal residues are dried, a crude extract is obtained; 2) subcritical extraction is conducted by using the fluid which is formed by dimethyl ether and butane according to the weight ratio of 60-70 : 30-40 as an extraction agent, the extraction temperature is 68-72 DEG C, the extraction pressure is 2.8-3.2MPa, and the extraction time is 20-40min. According to the method for extracting the alpha-mangostin from the garcinia mangostana peel, water extraction and alcohol extraction are used for obtaining the crude extract first in the extracting process, the content of the alpha-mangostin of the crude extract is 70%-80%, then subcritical extraction is conducted, and the content of the alpha-mangostin is further made to reach 98%. The method is short in time, small in dosage of reagents, simple in step and high in yield and content, a subcritical extraction agent is volatilized directly to obtain a product, and thus the method is more suitable for industrial production.
Owner:三原金瑞生物工程有限公司

Garcinia mangostana L. enhanced animal food product

InactiveUS20070087108A1Significant health advantageBiocideAnimal feeding stuffBiotechnologyAnimal food
The present invention advances prior art animal food products by providing an animal food product formulated with Garicinia mangostana L., or Mangosteen fruit, from the Mangosteen plant. The addition of Mangosteen to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.
Owner:TAHITIAN NONI INT INC

Preparation method of garcinia mangostana-based carbon nanodot and application of carbon nanodot to detecting ferric ions as fluorescent probe

The invention relates to a preparation method for a garcinia mangostana-based carbon nanodot and application of the carbon nanodot as a fluorescent probe to detecting ferric ions, and aims to solve the technical problem that an existing preparation method of the carbon nanodot is time-consuming. The preparation method of the carbon nanodot comprises the following steps: putting pulp of garcinia mangostana into a crucible for roasting and drying to obtain a solid; then, heating the solid in an electrothermal furnace, and cooling and crushing after the solid turns yellow brown from white in color to obtain yellow brown powder; dissolving the yellow brown powder with ultrapure water, magnetically stirring, performing ultrasonic treatment and centrifugally extracting supernate; filtering and dialyzing the supernate, and drying and crushing obtained carbon nanodot solution in vacuum to obtain carbon nanodot powder (MCDs). The carbon nanodot powder can serve as the fluorescent probe to interact with the ferric ions, so that fluorescence of the MCDs is quenched and a MCDs-Fe<3+> compound is formed, and therefore, detection on the ferric ions is realized. The fluorescent probe can be used in the field of fluorescent sensors.
Owner:QIQIHAR UNIVERSITY

External traditional Chinese medicine composition for treating female pruritus vulvae and preparation method thereof

ActiveCN103223110AHeat-clearing and damp-dryingWith detoxification and sterilizationAntimycoticsUnknown materialsSide effectPersicaria chinensis
The invention discloses an external traditional Chinese medicine composition for treating female pruritus vulvae, which is prepared from the following traditional Chinese medicine raw materials: rhizoma picrorhizae, persicaria chinensis, Shoulang yam, senecio scandens, adina rubella hance, red-knees herb, operculate cleistocalyx leaf, trogopterus dung, ardisia crenata, rhus chinensis mill, radix astragali, Chinese angelica, rhizoma polygonati, fructus psoraleae, semen cuscutae, four-leaf ginseng, panicled fameflower root, dogwood, schisandra chinensis, dark plum, pericarpium granati, tetracera asiatica stem and leaf, creeping oxalis, garcinia mangostana, lantana camara branches, fructus evodiae, clove and mint. The composition disclosed by the invention realizes an obvious effect on treating female pruritus vulvae, prevents toxic and side effect as well as irritation, and is convenient to use; and the effective rate is 100%, and the cure rate is 96%.
Owner:广州暨兴健康产业有限公司

Functional factor reinforced crunchy candy and processing method thereof

The invention discloses a functional factor reinforced crunchy candy and a processing method thereof. The processing method comprises the following steps: firstly, mixing 35 to 55 parts of isomaltose hypgather powder, 10 to 20 parts of erythritol powder, 10 to 20 parts of isomalt powder, and 25 to 35 parts of water and heating to a temperature of 70 to 90 DEG C to enable sugar to be molten; and then sugaring off, cooling, separating sugar semifinished products, preparing peanut butter rich in a garcinia mangostana L pericarp compound coating, crisping to make a core, whitening to prepare couverture and forming, wherein the peanut butter rich in the garcinia mangostana L pericarp compound coating is prepared by compounding a compound A, a compound B, a compound C and vitamin C which are separated from garcinia mangostana L pericarp according to a weight ratio of 1:(1-2):(1-2):(1-2) to form a garcinia mangostana L pericarp active material compound coating and adding the garcinia mangostana L pericarp active material compound coating into peanut butter. According to the invention, a heat value of the cushion is reduced; functions of not decaying teeth, removing free radicals, conditioning intestinal tract and the like and an antioxidation function are given to the cushion; and preservation performance of the cushion is improved, so that shelf life is prolonged.
Owner:ZHONGKAI UNIV OF AGRI & ENG

Preparation method of alpha-mangostin

The invention relates to a preparation method of alpha-mangostin and the method has simple operation, low pollution and less energy consumption. The method comprises the following process steps: taking the shells of Garcinia mangostana Linn. to grind, adding the grinded shells in a CO2 supercritical extractor, using ethanol as the entrainer to obtain an extract; adding the extract in a polyamide chromatography column, using a mixed solvent of dichloromethane and methanol in a volume ratio of 8:1 as the eluting agent to perform elution, performing matching detection by drop a part of eluent on a polyamide film and using the eluting agent for developing, collecting the fluid phase which has 4-4.5 of Rf on the polyamide film, recycling the solvent, crystallizing, separating the crystals, recrystallizing with toluene, separating the crystals, washing and drying. By adopting the method of the invention to prepare alpha-mangostin, the product purity is high and the industrial amplification production is easy to realize.
Owner:SUZHOU PAITENG BIOLOGICAL MEDICAL TECH

Composite nutritional food

The present invention provides a composite nutritional food which includes the following raw materials: wheat, rice, coix chinensis, barley, fagopyrum esculentum, red beans, black beans, mung beans, corn grains, black sesame seeds, carrots, purple cabbages, tomatoes, pleurotus eryngii, cucurbita pepo, pumpkins, tremella, syzygium samarangense, coconut meat, papayas, persea americana, averrhoa carambola, garcinia mangostana, grape seeds, crab shells, shrimp shells, hippophae rhamnoides fruits, chrysanthemums, schisandra chinensis, ganoderma lucidum, panax quiquefolium, Chinese wolfberry fruits, dry lotus leaves, oysters, poria cocos, prunes, virgate wormwood herb, mentha haplocalyx leaves and other raw materials. The composite nutritious food recipe includes various functional components and nutritional components of natural polysaccharides, flavonoids, triterpenoids, saponins, peptides, vitamins, minerals, etc. The low-fat and high-protein ingredients can meet the daily nutrients needed by human body, maintain normal human body functions, increase satiety, have functions of enhancing human body immune function, regulating intestinal flora, preventing cardiovascular and cerebrovascular diseases, etc., and is a weight losing and body shaping food having non-toxic or side effects on human body.
Owner:宣海燕

Oral compound drug for treating oral ulcer

The invention discloses an oral compound drug for treating oral ulcer. The oral compound drug provided by the invention is made from the following components of: by weight, 12 parts of fried Garcinia mangostana, 15 parts of fried tingli seed, 12 parts of fried Plantain seed, 12 parts of calcined gypsum, 12 parts of calcined Borax, 12 parts of calcined calamine, 12 parts of calcined Renzhongbai, 10 parts of dried alum, 9 parts of lime, 12 parts of talcum, 3 parts of borneol, 0.2 part of streptomycin and 0.2 part of erythromycin. The drug for treating oral ulcer has advantages of high cure rate, remarkable effects, drug source easily available, no phytotoxicity and low price. The effective rate reaches 95% and the cure rate reaches 92.5%.
Owner:杨再新

Method for separating and purifying alpha-mangostin from garcinia mangostana

The invention relates to a preparation method for plant extract, in particular to a method for separating and purifying alpha-mangostin from garcinia mangostana. According to the method, hydrophily-loaded organic carbon black is prepared and utilized for adsorbing garcinia mangostana bark powder, and the alpha-mangostin is extracted through the steps of acid precipitation, separating filtering and extracting. The method has the advantages that the extraction rate is high, and the purity of the extract reaches over 99.9%; the operation steps are simple, and the technological process is simplified; the needed cost is low.
Owner:CHANGZHOU DINGRI ENVIRONMENTAL PROTECTION TECH

Lecithin milk drink and its producing method

The invention relates to a kind of the lecithin milky beverage. It contains (Wt.% per ton): fresh milk 200-400kg, sugar 40-60kg, asparteme 0.8-1.2kg, dairy stabilizer 4-6kg, citric acid monohydration 2-4kg, llactic acid 1-2Kg,sodium citrate 0.1-0.5Kg,lecithin 0.5-1.5Kg,milk flavor 0.1-0.4Kg,Citrus garadis flavor 0.2-0.4Kg,grapefruit flavor 0.1-0.3Kg,Garcinia mangostana L. flavor 0.1-0.3Kg,remaining water. Such product has the merit both of the nutrition from the milk and the lecithin function. It mainly works on dissolving the cholesterin,antiatherogenic;activation of the cells;activation of the brain enginery,prevention of the senile dementia;being young and long live, protecting your liver function. Alcohol and high cholesterin are two mainly factors to hepar adiposum and hepatocirrhosis, on the contrary, the lecithin can restore the damaged liver cells.
Owner:辽宁优格生物科技股份有限公司

A blend selected from Asteraceae tomentosa and Mangosteen for metabolic syndrome control

The invention relates to pharmaceutical / dietary supplement / food ingredient(s) selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from Sphaeranthus indicus and their compositions, preferably in combination with at least one component selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from Garcinia mangostana. The ingredients and the composition(s) can be used for the control, prevention and treatment of obesity, metabolic syndrome, diabetes and other metabolic disorders, and also to regulate energy expenditure, prevention of atherosclerotic plaques in coronary artery and abdominal aorta, increase insulin sensitivity, improve glucose tolerance, lower triglyceride levels and balance glucose levels in mammals.
Owner:LAILA NUTRACEUTICALS

Bubble makeup holding foundation and preparation technology thereof

The invention discloses a bubble makeup holding foundation and a preparation technology thereof. The bubble makeup holding foundation is prepared from the following components: deionized water, an acrylic acid (ester) / C10-30 alkanol acrylate crosslinked polymer, butylene glycol, glycerinum, triethanolamine, polydimethylsiloxane, a polydimethylsiloxane crosslinked polymer, cetacean lipidol ethyl caproate, octane polysiloxane, lauryl PEG-9 polydimethyl silica ethyl polydimethyl siloxane, tocopherol acetate, titanium dioxide, ferrite yellow, iron oxide red, iron black, triethoxy octyl siloxane, talcum powder, quaternary ammonium salt-18 bentonite, glycerin stearate, cetostearyl alcohol, sodium stearoyl lactylate, C30-45 alkyl polymethylsiloxane, C30-45 alkene, phenoxyethanol, dipropylene glycol, polysorbitan-200, a garcinia mangostana peel extract, a mangnolia officinalis bark extract and a punica granatum pericarp extract. According to the bubble makeup holding foundation and the preparation technology thereof, the foundation with clear skin sense and makeup holding with a special bubble appearance can be obtained, and scale volume production can be realized through the preparation technology.
Owner:SUZHOU ANTE COSMETICS CO LTD

Formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases

The invention relates to a formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases and discloses a main compound extracted from mangosteen:Garcinia mangostana. In the main compound, alpha-mangostin serving as a main ingredient is used in combination with various common filters in pharmaceuticals industry to prepare various proper formulations including tablets, capsules, powders, suppositories and the like for oral or external use for treating and preventing arthritis diseases such as rheumatoid arthritis, chronic infectious arthritis, post-traumatic arthritis, osteoarthritis and purulent arthritis as well as complicating diseases of the arthritis diseases such as inflammations of finger joints, metacarpophalangeal joints, wrist joints, elbow joints, shoulder joints, knee joints, spondyl joints, ankle joints, metatarsophalangeal joints and other joints. The alpha-mangostin content of the product of the invention is between 0.1 and 99.9 percent. The product manufactured by the formula can relieve the various inflammations and has certain analgesic effect. The product can be used alone or in combination with other substances.
Owner:陈霞

External breast enlarging drug and preparation method thereof

InactiveCN107308438ACosmetic preparationsPeptide/protein ingredientsCASSIA FISTULA FRUITMedicine
The invention relates to an external breast enlarging drug and a preparation method thereof. A raw material for preparing the external breast enlarging drug comprises the following components in parts by weight: 0.05-0.3 part of a garcinia mangostana peel extract, 2-6 parts of cassia fistula fruit flavonoid, 2-6 parts of hop flavonoid, 1-5 parts of a pyrus cydonia seed extract, 0.5-2 parts of a radix puerariae extract, 0.5-2 parts of a chlorella and white lupine protein co-fermentation product, 1-4 parts of Indian myrrh resin, 8.5-21 parts of grease, 3-6 parts of an emulsifying agent, 8.1-16.2 parts of a moisturizing agent, 0.4-0.9 part of a thickening agent and deionized water. The external breast enlarging drug has better breast enlarging and breast firming effects.
Owner:SHENZHEN YONGJITAI TECH

Traditional Chinese medicine preparation for treating gastric and duodenal ulcers

The invention relates to a traditional Chinese medicine preparation for treating gastric and duodenal ulcers. Medicines of the traditional Chinese medicine preparation meet the principle of compatibility of traditional Chinese medicines; firstly root of woolly lespedeza, pseudo-ginseng flower, pseudo-ginseng leaves, gynostemma pentaphyllum, garcinia mangostana, ginseng leaves, cherry leaves, root of jobstears, leaf of jobstears, root of Indian abutilon, medicated leaven with beef paste and sandalwood resin are fundamentally used as monarch drugs and ministerial drugs for tonifying spleen and vital energy, increasing physical immunity, and promoting healing of the ulcers; cladonia verticillata hoffm, begonia, all-grass of irisleaf oberonia, leaf of trifoliate-orange, pericarp of pummelo, persimmon frost, root and bark of mock orange, Chinese alangium flower, Indian kalimeris herb, snow lotus herb, hericium erinaceus and royal jelly are used as adjuvants for harmonizing, reinforcing the functions of the monarch drugs and the ministerial drugs and limiting toxic and side effects of other drugs. By virtue of the cooperation of the drugs, the pharmaceutical effect is mild and durable, and the efficacies of promoting blood circulation, removing blood stasis, invigorating spleen, supplementing the vital energy, promoting tissue regeneration and relieving pain are achieved. The rationality of the traditional Chinese medicine preparation is proved by the modern pharmacological research; the traditional Chinese medicine preparation has remarkably treating effects equivalent to the treatment effects of Western medicines on the clinic treatment of gastritis and duodenal ulcer and is worthy of being further generalized.
Owner:杜卫兵

Plant composite sun-screening agent and preparation and application thereof

The invention relates to the technical field of cosmetics, in particular to a plant composite sun-screening agent and preparation and application thereof. The plant composite sun-screening agent is prepared by compounding angelica keiskei extract, roxburgh rose extact and garcinia mangostana L. pericarp extract. The plant composite sun-screening agent is prepared by compounding the angelica keiskei extract, the roxburgh rose extact and the garcinia mangostana L. pericarp extract according to a certain ratio, long-wave ultraviolet and medium-wave ultraviolet can be well absorbed, and a good sun-screening effect is achieved. In addition, the plant composite sun-screening agent further has very good anti-oxidation capacity, free radicals generated when the ultraviolet irradiates skin of the human body can be removed, a certain tyrosinase activity inhibition ratio is achieved, a certain skin whitening effect is achieved, and very good cosmetic application potential is achieved.
Owner:DONGGUAN BOTON FLAVORS & FRAGRANCES

Prescription for treating prostatitis and other reproductive system diseases of male

The invention relates to a formula for treating prostatitis and other male reproductive system diseases. The invention discloses a main compound extracted from mangosteen: Garcinia Mangostana, wherein alpha-mangostin is taken as a main effective constituent and mixed with various commonly used fillers in the medicine industry to prepare various appropriate preparation formulations including tablets, capsules, powder, and suppository; and the various preparation formulations can be used for preventing and treating male reproductive system inflammations such as prostatitis, orchitis, deferentitis and urethritis by means of oral taking or external application. The content of the alpha-mangostin in the product is between 3 and 99.8 percent; and the prepared product can relieve various inflammations, has the function of relieving pain to certain degree, and can be independently used or mixed with other natural substances for use.
Owner:王莉

Lonicera caerulea edible lip balm and preparation method thereof

The invention provides a lonicera caerulea edible lip balm which is made of natural materials, safe in used materials, good in moisturizing effect, long in lip skin adhering time and simple in preparation process and a preparation method thereof. The lonicera caerulea edible lip balm is prepared from the following raw materials, by weight, of 20-30 parts of lonicera caerulea extractives, 10-15 parts of moringa seed oil, 15-25 parts of coconut oil, 10-20 parts of olive oil, 15-25 parts of sweet almond oil, 10-15 parts of sunflower oil, 10-20 parts of garcinia mangostana oil, 10-20 parts of shea butter, 60-80 parts of beewax and 1 part of vitamin C. According to the lonicera caerulea edible lip balm and the preparation method thereof, the purely natural and food grade safe raw materials are adopted, any harm to human bodies is avoided, adaptability is high, the ratio is reasonable, adhesiveness and the moisturizing effect is ideal, and the preparation process is simple.
Owner:张馨之

Anti-adipocyte fatty acid-binding protein (AP2), anti-flap and anti-CySLT1 receptor herbal compositions

Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of Boswellia serrata. More particularly, these herbal compositions comprise an effective amount of an enriched Boswellia extract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-β-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of Aegle marmelos, an extract of Zingiber officinale, an extract of Garcinia mangostana, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.
Owner:LAILA IMPEX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products